Dermocosmetics Push Yields Results For Switzerland's Galenica
Launching skin-care products that blend "natural medicinal plants from the Swiss pharmacopoeia with the best Swiss skin science" helped to drive up Galenica's OTC sales in 2019 at a double-digit rate.
You may also be interested in...
Switzerland's Laboratoires Diepharmex has been snapped up by Cooper-Vemedia, the pan-European consumer healthcare group backed by private-equity firm Charterhouse Capital Partners.
Galenica's Verfora took the lead in the Swiss consumer health market for the first time ever in 2018, ahead of its multinational rivals. But the firm is not stopping there. It has acquired a stake in local complementary medicines player Spapyros to take a slice of the poplar homeopathy market.
Swiss medicines authority, Swissmedic, rules that hundreds of non-prescription medicines are safe to be purchased outside pharmacy, following the completion of its review of the country's medicines classification system.